January 8, 2014 — Dilon Technologies Inc. announced that it acquired the assets of the Navigator gamma probe business from RMD Instruments Corp., manufacturer and marketer of intraoperative surgical probes and subsidiary of Dynasil Corporation of America.
The acquired products are used in surgery for procedures such as sentinel lymph node biopsy and pulmonary wedge resection. The company recently introduced its Navigator 2.0 wireless probe.
"In addition to our market leadership in the small field of view molecular breast imaging market, this acquisition is consistent with our objective of expanding our product offering in both the diagnostic and surgical segments of the market and comes on the heels of our recent agreement with Digirad," said Robert Moussa, CEO, Dilon.
"We are pleased to have found a wonderful home for our Navigator probe technology, one of the most widely used gamma probes for cancer surgery in the marketplace. Dilon Technologies is well situated to expand the gamma probe market and we look forward to working with them over the coming months to transition the product from our manufacturing facility to Dilon," said Peter Sulick, chairman and interim CEO, Dynasil.
For the time being, Dynasil will continue to manufacture and distribute the products, ensuring continuity in supply and regulatory compliance.
For more information: www.dilon.com, www.dynasil.com, rmdinc.com
October 01, 2026 
